Physician profile

Mohammed Ameen

Dentist · Traverse City, MI

NPI 1821657172

$261.52

in general payments reported to CMS, 2019-2025

3 companies · $133 in 2025

The $133 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$70.86
Education$50.00
Gift$37.27

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Align Technology, INC. $209.36 2020-2025 Invisalign, Invisalign Go
Straumann USA LLC $37.27 2025
Dentsply Sirona INC $14.89 2025 Midwest E Plus

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Mohammed Ameen

$261.52

in general payments reported 2019-2025

Years
2020-2025
Top company
Align Technology, INC.
Context
The $133 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).

https://glasscript.com/doctor/6715994/mohammed-ameen

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.